Dear Valued Customer,
Thank you for your continued support of SOFIVA GENOMICS.
In order to provide more comprehensive cancer genetic testing service, we will discontinue the EGFR Gene Mutation Testing from March 31st 2023, and launch a more comprehensive genetic testing - SOFIVA Cancer Monitor – Lung. The testing can detect 26 genes, including EGFR, KRAS ALK, ect. by Next-Generation Sequencing (NGS) in a single assay, providing more information on personalized precision medicine approach.
For further information, please visit the official website of SOFIVA GENOMICS (www.sofivagenomics.com).

For any questions or concerns regarding these changes, please kindly contact us.
E-mail: [email protected]